Comparing Two Protocols of Shock Wave Therapy for Patients With Plantar Fasciitis
Launched by UNIVERSITY OF SHARJAH · Dec 7, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of shock wave therapy to see which one works better for treating plantar fasciitis, a common condition that causes heel pain. The trial aims to find out how effective each therapy is in helping people move better and feel less pain after six treatment sessions. Participants will be placed into one of three groups: one group will receive a specific type of shock wave therapy with a higher frequency, another group will receive a different type of therapy, and the third group will get a sham treatment that feels similar but doesn’t provide any real benefits.
To take part in the trial, individuals should be between 20 and 50 years old and have been experiencing pain in one foot for at least six weeks. They should also have moderate difficulty in foot function and a normal body weight. Participants will fill out questionnaires about their pain and foot function before, during, and after the treatments to track their progress. The results of this study could help develop better treatment guidelines for plantar fasciitis, potentially leading to quicker recovery times for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The participants should present with unilateral pain
- • 2. The participants' age will be ranged from 20-50 years old.
- • 3. The participants should have the pain from for at least 6 weeks.
- • 4. Moderate disability as assessed by the foot function index (FFI)
- • 5. The Body Mass Index (BMI) should be normal.
- • 6. The participants should have pronated feet (6-9 on the foot posture index)
- Exclusion Criteria:
- • 1. History of surgery or fracture
- • 2. History of corticosteroid injection within 6 months
- • 3. Unable to follow or understand the instructions
- • 4. High BMI
- • 5. Severe foot pronation (+10 on the foot posture index)
About University Of Sharjah
The University of Sharjah, a leading academic institution in the United Arab Emirates, is dedicated to advancing healthcare through innovative research and education. With a robust commitment to clinical excellence, the university actively sponsors clinical trials that aim to address pressing health challenges and improve patient outcomes. Leveraging state-of-the-art facilities and a multidisciplinary team of experts, the University of Sharjah fosters a collaborative environment that enhances the quality and impact of its research initiatives, ultimately contributing to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Fatima Alkalbani, Bsc
Principal Investigator
PRS User
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported